Mini-dose MTX Plus Standard-dose Steroid for the Initial Treatment of Acute GVHD

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This trial is a randomized (1:1) phase III open label study of frontline mini-MTX plus methylprednisolone 2mg/kg/day compared to methylprednisolone 2mg/kg in allogeneic stem cell transplant recipients with grade 2-4 aGVHD.
Epistemonikos ID: ca3ab8fe9d643c93b871cc0749510eaca2d3cd70
First added on: May 15, 2024